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doi:10.1016/j.jtcvs.2003.11.0571000 The Journal of Thoracic and CardObjective: We sought to define the prevalence of definitive end states and their
determinants in children given a diagnosis of pulmonary atresia and intact ventric-
ular septum during the neonatal period.
Methods: Between 1987 and 1997, 408 neonates with pulmonary atresia and intact
ventricular septum were entered into a prospective study by 33 institutions. Com-
peting risks analysis was used to demonstrate the prevalence of 6 end states. Factors
predictive of attaining each end state were identified by means of multivariable
analysis with bootstrap validation.
Results: Overall survival was 77% at 1 month, 70% at 6 months, 60% at 5 years, and
58% at 15 years. Prevalence of end states 15 years after entry were as follows:
2-ventricle repair, 33%; Fontan repair, 20%; 1.5-ventricle repair, 5%; heart trans-
plant, 2%; death before reaching definitive repair, 38%; and alive without definitive
repair, 2%. Patient-related factors discriminating among end states primarily in-
cluded adequacy of right-sided heart structures, degree of aberration of coronary
circulation, low birth weight, and tricuspid valve regurgitation. After adjusting for
these factors, 2 institutions were predictive of 2-ventricle repair, 1 of Fontan repair,
and 6 of death before definitive repair. Two institutions were predictive of both
2-ventricle and Fontan repair. These 2 institutions achieved a higher risk-adjusted
prevalence of definitive repair and a lower prevalence of prerepair mortality.
Conclusions: Characteristics of neonates with pulmonary atresia and intact ventric-
ular septum predict type of definitive repair. A morphologically driven institutional
protocol emphasizing both 2-ventricle and Fontan pathways might mitigate the
negative effect of unfavorable morphology. In the current era, 85% of neonates are
likely to reach a definitive surgical end point, with 2-ventricle repair achieved in an
estimated 50%.
Pulmonary atresia with intact ventricular septum (PAIVS) is charac-terized by the absence of communication between the right ventricleand the pulmonary trunk or the left ventricle. The lesion is morpho-logically heterogeneous, with varying degrees of right ventricular(RV) and tricuspid valve hypoplasia.1 Aberrations of coronary circu-lation are common, ranging from cameral-coronary sinusoids and
2fistulas to right ventricle–dependent coronary circulation.
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DA prior report from the Congenital Heart Surgeons So-
ciety (CHSS) examined various morphologic substrates and
optimal initial palliative pathways for the initial 171 neo-
nates enrolled with PAIVS.3 Since that report, an additional
237 neonates were enrolled, and the present cohort includes
all 408 neonates. We undertook this multi-institutional anal-
ysis to determine the proportion of neonates reaching de-
fined end states, to identify factors predictive of each end
state, and to synthesize these findings in a way that would
reveal which factors are associated with a greater proportion
of neonates reaching definitive repair.*
Patients and Methods
Patients
From January 1987 through April 1997, 408 neonates with PAIVS
admitted to a CHSS institution within 30 days after birth were
prospectively enrolled in a multi-institutional study. PAIVS was
defined as no communication between the right ventricle and the
pulmonary trunk and the absence of a ventricular septal defect, as
determined on the basis of echocardiographic, catheterization, or
surgical findings. Neonates were managed at 33 member institu-
tions, with a median enrollment of 10 neonates per institution
(range, 1-41 neonates). Mean birth weight was 3.1  0.6 kg.
The median tricuspid valve z score was 1.2 (range, 5.4 to
6.0). Of 334 neonates for whom RV size was known, it was small
for age in 303 (91%) and moderately or severely so in 49% (Table
1). tricuspid valve z score and RV size were moderately correlated
(r 0.60, P .001). Right ventricle–coronary artery fistulas were
present in 126 (31%). Right ventricle–dependent coronary circu-
lation, defined as supply of a major portion of the left ventricle
from only the right ventricle through a fistula or fistulas, was
present in 19 (5%) neonates. Coronary aberrations were primarily
associated with moderate or severe hypoplasia of right-sided heart
structures.3
Morphology
Morphologic data were obtained by means of independent review
of preintervention echocardiograms and catheterization results, as
*A preliminary analysis of end states in 346 neonates was presented by
E. H. Blackstone, J. W. Kirklin, and F. L. Hanley at 69th Scientific Session,
TABLE 1. Morphologic characteristics in 334 neonates for
RV size n % of 334 Median
5 (severe hypoplasia) 62 19% 2.3
4 100 30% 2.3
3 79 24% 1.1
2 40 12% 0.3
1 22 7% 0.4
0 (normal for age) 16 5% 1.5
1 (enlarged) 15 4% 2.4
RV, Right ventricle/right ventricular; CA, coronary artery.
*High upper limits of tricuspid valve z score in neonates with a diminutivAmerican Heart Association, November 1996.
The Journal of Thoracicpreviously described.3 A subjective grade for RV size was as-
signed on the basis of available combined information from cath-
eterization, echocardiography, and surgical intervention. Normal-
for-age cavity size was assigned a value of 0, extreme hypoplasia
was assigned a value of 5, and intermediate degrees of hypopla-
sia were assigned values of 1 through 4. For enlargement, a
similar scheme was used, with 5 denoting the most extreme
enlargement.
Data Collection
Participation in the study and submission of patient information
was voluntary and confidential. Parental consent was obtained
consistent with individual institutional policies. Ethics approval for
the CHSS Data Center is obtained annually from the Hospital for
Sick Children in Toronto. Admission, diagnostic, interventional,
and surgical records were abstracted into a database by CHSS
members and staff.
Follow-up
The physician, family, or guardian of each child not known to have
died has been contacted annually to ascertain clinical status and
any intervening problems or procedures. After the most recent
cross-sectional follow-up in 2002, current data (within 1 year of
this analysis) were available for 373 (91%) children. For all
neonates, follow-up time from the date of the first hospital admis-
sion was a median of 5.8 years (range, 1 day to 15.6 years). For
surviving patients, median follow-up was 10.3 years (range, 1 day
to 15.6 years). For neonates without current data (n  35 [9%]),
median follow-up was 3.4 years (range, 1 day to 9.1 years).
Data Analysis
All analyses were performed with SAS statistical software (version
8; SAS Institute, Inc, Cary, NC). Data are presented as frequencies,
medians with ranges, or means  SD as appropriate.
End states. Mutually exclusive end states were designated,
including 2-ventricle repair, 1.5-ventricle repair (biventricular re-
pair with superior cavopulmonary connection), 1-ventricle repair
(completed Fontan operation with or without fenestration), pri-
mary heart transplantation, death before attaining a definitive re-
pair, and survival without definitive repair. Definitive repair was
defined as separation of systemic and pulmonary circulations (no
m an RV size score was assigned
uspid valve z score
RV-CA
fistulas
RV-dependent
coronary
circulationRange* 25th percentile
5.4 to 4.8 3.3 35 (56%) 5 (8%)
5.3 to 0.6 3.1 55 (55%) 10 (10%)
5.2 to 5.0 1.9 28 (35%) 4 (14%)
3.1 to 3.2 1.0 5 (13%) 0
2.9 to 2.9 1.2 3 (14%) 0
1.6 to 5.0 0.6 0 0
1.0 to 6.0 0.4 0 0
t ventricle are attributable to associated Ebstein’s malformation.who
Tric







e righextracardiac shunts and no intracardiac right-to-left shunts at the
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Datrial level), such that children undergoing fenestrated 2-ventricle
repair were not considered definitively repaired until the intra-
atrial shunt was known to be closed, either surgically or
spontaneously.3
Prevalence of end states. Non–risk-adjusted freedom from
each state was estimated nonparametrically by using the Kaplan-
Meier method. Rates of transition from the initial state of mixed
circulation to each competing end state was estimated by means of
hazard-function multiphase parametric modeling.4 By using com-
peting-risks methodology, the individual hazard functions were
integrated to yield the actual proportion of neonates reaching each
defined end state at any given time after initial hospital admission.5
Risk factors for end states. Demographic and morphologic
factors associated with each end state were sought by using mul-
tivariable regression of hazard models. Variable selection was
primarily performed by means of bootstrap bagging.6 For the
bootstrap step, randomly selected data sets (n  200) of the same
size as the original data set were analyzed by means of automated
stepwise regression, with an inclusion criterion of a P value of .05
or less. For the aggregation step, cluster analysis was used to
identify risk factors occurring in 50% or more of the analyses, with
the most commonly occurring transformation (if applicable) se-
lected. These factors were entered into a final model, and those
with P values of .05 or less were retained. Frequency of identifying
factors (reliability) according to bagging is reported. Parameter
estimates signify contribution of a variable to the overall model,
and their interpretation is affected by increments of measurement
and, where applicable, mathematic transformations.
Effect of institution. After adjusting for retained patient fac-
Figure 1. Non–risk-adjusted competing-risks depiction
children reaching each end state over time after initia
initial admission (time  0) and thereafter migrate to a
functions. At any point in time, the sum of the proportio
the estimated prevalences of end states are as follows:
repair, 5%; cardiac transplantation, 2%; death before re
Solid lines represent parametric estimates (surrounde
accumulative effect of each hazard function applicabl
each point in time. B, Parametric hazard functions (so
representing the instantaneous risk of attaining each o
admission. For clarity, the inset expands the 2-ventrictors, institutions associated with each end state were identified in
1002 The Journal of Thoracic and Cardiovascular Surgery ● Apra similar manner. The competing-risks model containing patient
factors was repeated, entering each institution identified as a risk
factor for 2-ventricle repair, for the Fontan operation, and for death
before definitive repair to further assess institutional outcomes.
Adjusting outcomes for each institution on the basis of neonates
managed in it allows comparison among institutions in a risk-
adjusted manner. Nomograms of individual institutional outcomes
on the basis of the morphologic spectrum (tricuspid valve z score
with concordant RV size adjustment) of PAIVS were constructed.
Results
For all 408 neonates, survival at 1 month, 6 months, 1 year,
5 years, and 15 years after initial admission was 80%, 70%,
68%, 60%, and 58%, respectively. Risk factors for death at
any time were similar to those described below. There was
improvement in overall survival across the study period.
Holding other factors constant, predicted 5-year overall
survival for neonates enrolled in 1987, 1992, and 1997 was
49%, 63%, and 79%, respectively.
Prevalence, Timing, and Factors Predictive of End
States
Prevalence of neonates reaching a definitive end state was
49%, 89%, 96%, and 98% at 1, 5, 10, and 15 years after
initial hospital admission, respectively (Figure 1, A). Instan-
taneous rates of reaching each end state at any given time
after entry are shown in Figure 1, B. Incremental risk factors
nd states in 408 neonates with PAIVS. A, Proportion of
pital admission. All patients begin alive at the time of
d state at a time-dependent rate defined by the hazard
hildren in each state is 100%. For example, at 5 years,
ntricle repair, 28%; Fontan operation, 19%; 1.5-ventricle
g a repair state, 36%; and alive without end state, 11%.
their 70% confidence intervals in dashed lines) of the
patients remaining alive without a definitive repair at
urves) with 70% confidence intervals (dashed curves)
nd states at any given time up to 15 years after initial
zard function.of e
l hos
n en
n of c
2-ve
achin
d by
e to
lid c
f 5 efor each end state are shown in Table 2.
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DCompleted 2-ventricle repair (n 120). The prevalence
of completed 2-ventricle repair was 13%, 28%, and 33% at
TABLE 2. Incremental factors associated with reaching e
atresia with intact ventricular septum
Factor Pa
2-ventricle repair
Early phase
RV size* closer to normal
TV z score closer to normal (per 1 SD)
Higher LV pulse pressure (per 5 mm Hg)
Institution E
Late phase
Lesser degree of RV-CA fistula(s)†
TV Z score‡ closer to normal (per 1 SD)
RV size* closer to normal
Higher birth weight (per 1 kg)
Institution M
Institution B
Institution L
Institution E
1.5-ventricle repair
Early phase
Higher RV systolic pressure (per 10 mm Hg)
TV z score closer to normal (per 1 SD)
Institution G
Institution A
1-ventricle repair
Early phase
Lower TV z score‡
Institution T
Institution E
Institution M
Heart transplantation
Early phase
Later date of admission (per 1 y)
Institution R
Death before attaining definitive repair
Early phase
Lower birth weight§
Severe TV incompetence
Lower (and higher) TV z score
Enlarged RV
Institution Y
Institution D
Institution H
Institution S
Late phase
Lower RV:LV systolic pressure ratio
Prior balloon atrial septostomy
Earlier date of admission¶ (per 1 y)
Institution C
Institution P
TV, Tricuspid valve; RV, right ventricle/right ventricular; LV, left ventricle;
*Grade of RV size entered after square transformation.
†Graded spectrum ranging from no fistulas to fistulas with severe RV-dep
‡Entered after exponential transformation.
§Entered after inverse transformation.
Entered after square transformation.
¶Measured as time since October 1, 1987: entered after logarithmic trans1, 5, and 15 years after admission, respectively. The instan-
The Journal of Thoracictaneous rate revealed 2 major phases. An early phase, start-
ing near the time of admission and extending to 3 months,
of 5 defined end-states in 408 neonates with pulmonary
ter estimate  SE P value Reliability (%)
.32 0.08 .001 99
.27 0.12 .026 54
.26 0.11 .020 55
.28 0.64 .044 56
.62 0.18 .001 95
.79 0.94 .003 75
.25 0.10 .014 72
.51 0.25 .042 56
.74 0.63 .007 78
.91 0.44 .040 54
.79 0.54 .001 70
.84 0.41 .042 52
.31 0.11 .007 60
.32 0.12 .010 73
.62 0.61 .001 86
.10 0.72 .004 84
.00 0.92 .001 91
.94 0.36 .001 97
.38 0.51 .001 90
.47 0.53 .006 83
.42 0.13 .002 93
.61 0.80 .002 72
.32 1.18 .001 84
.47 0.28 .001 90
.28 0.08 .001 75
.31 0.32 .001 75
.26 0.33 .001 91
.23 0.46 .008 66
.44 0.40 .001 86
.90 0.29 .003 83
.87 0.35 .014 81
.41 0.52 .007 50
.00 0.27 .001 63
.06 0.65 .002 71
.01 0.78 .010 58
oronary artery.
nt coronary circulation.
tion.ach
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enderepresented 25 neonates with favorable morphology. The
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Dsubsequent late hazard phase included 95 children, in-
creased beyond 2 months, and spans the remainder of the
study period. It corresponds to the wide time frame for
closing extracardiac and intra-cardiac shunts.
Fontan operation (n  76). The prevalence of Fontan
repair was 1%, 19%, and 20% at 1, 5, and 15 years after
admission, respectively. There is a single hazard phase for
the Fontan operation peaking at 3 years.
Other definitive repairs (n  31). The 15-year preva-
lence of 1.5-ventricle repair and cardiac transplantation was
5% and 2%, respectively.
Death before definitive repair (n  149). The preva-
lence of death before definitive repair was 31%, 36%, and
38% at 1, 5, and 15 years after admission, respectively, and
was heavily concentrated around the time of first admission.
For neonates not reaching a definitive repair within the first
2 years of life, there was an ongoing late hazard for death.
Predicted Pathway
From patient factors in Table 2, predicted 1- or 2-ventricle
pathway was determined for each neonate. The 2-ventricle
pathway was predicted for 246 (60%) neonates, and the
1-ventricle pathway was predicted for 162 (40%) neonates.
The management protocol matched the predicted protocol in
315 (77%) neonates. An increased prevalence of death
before reaching definitive repair was observed for neonates
managed differently from the predicted pathway (54% vs
31%, P  .001).
Effect of Institution
A competing-risks model was constructed for each institu-
tion identified as a risk factor for one or more end states.
Nomograms illustrating the risk-adjusted 5-year prevalence
of end states for representative institutions favoring 2-ven-
tricle, Fontan, and both 2-ventricle and Fontan pathways are
shown in Figure 2. Institutions favoring 2-ventricle repair
on average achieved a higher prevalence of 2-ventricle
repair at a cost of higher prerepair mortality (Table 3). Such
institutions might improve outcomes through more aggres-
sive application of the Fontan pathway in children with less
favorable morphology (Figure 2, A).
The single institution favoring Fontan repair achieved
good survival at the cost of fewer 2-ventricle repairs, even
for more favorable morphology (Table 3). Such institutions
might improve outcomes by applying 2-ventricle repair to
children with favorable morphology (Figure 2, B).
Two institutions applied both 2-ventricle and Fontan
pathways in a morphologically dependent manner (Figure 2,
D) to achieve comparably excellent survival and higher
prevalence of 2-ventricle and Fontan repairs, with few re-
maining unrepaired at 5 years (Table 3).
High-risk institutions, with the exception of institution
H, demonstrated a reticence toward committing to either a
1004 The Journal of Thoracic and Cardiovascular Surgery ● Apr2-ventricle or Fontan pathway, as indicated by the high
prevalence of children alive without a definitive repair at 5
years compared with numbers in low-risk-factor institutions
(Figure 2, C).
Discussion
PAIVS is a rare lesion, and most previous reports include
small numbers of children treated at a single institution.7-13
A unique aspect of our study made possible by the large
unselected population of neonates accrued by CHSS insti-
tutions is consideration of various mutually exclusive end
states achieved in these neonates. By accounting for multi-
ple simultaneous outcome events, competing risks methods
allow determination of the actual prevalence of each end
state over time after entry, multivariable definition of pa-
tient-related factors associated with the distribution of end
states, and demonstration of the risk-adjusted effect of in-
stitution on the prevalence of end states.
Although variable, reported survival in neonates with
PAIVS has improved over time. In an earlier era, reported
5-year survival among 135 neonates admitted between 1970
and 1989 was less than 50%, with 25% of children deter-
mined to be suitable for definitive repair.14 The overall
5-year survival in our multi-institutional study was 60%,
with adjusted 5-year mortality for neonates admitted in later
years of 79%. The proportion reaching definitive repair at 5
years was 52%. Our data are similar to those of a national
Swedish study of 84 children born between 1980 and
1999.15 Several recent reports have documented outstanding
survival, ranging from 76% to 98% at 5 years.9,12,13 Despite
excellent survival, the proportion undergoing definitive re-
pair in these studies was 55% to 72%.
The morphologic spectrum of PAIVS requires different
management protocols with the goal of maximizing the
number of neonates reaching appropriate definitive repair.
From the institutional findings of this study, we infer that
surgical protocol on the basis of individual risk factors
present might optimize outcomes. Findings of this and the
initial CHSS study show that the decision process must
begin at the time of initial admission.3
Our study demonstrates that an optimal protocol empha-
sizes the 2-ventricle pathway for favorable morphology and
the Fontan pathway for unfavorable morphology. Such a
protocol results in a higher proportion of neonates reaching
a definitive repair, earlier completion of definitive repair,
and a lower proportion of prerepair attrition. We have
shown that such a protocol at least in part mitigates the
negative effect of hypoplastic right-sided heart structures on
survival. Selecting a Fontan pathway for children with mar-
ginal or severe anatomy should not be considered a failure
of therapy.11,16 The benefits of selective management are
12,13supported by several previous reports.
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DThe method of risk adjustment warrants further explana-
tion. Multivariable analysis of patient factors identified im-
portant variables in predicting the prevalence of each end
state, with the weight of each factor determined from the
overall data. In contrast to risk stratification, institutions
associated with a comparably high prevalence of one or
more end states were identified after adjusting for important
patient variables (ie, institutions predisposed to a particular
end state after consideration of their patient population).
Figure 2. Risk-adjusted competing-risks nomograms
spectrum of PAIVS. The predicted 5-year prevalences
valve z scores with commensurate adjustment of RV
Institution L favored 2-ventricle repair. For favorable
achieved. For unfavorable morphology, the rate of Fon
small proportion of patients remain alive without defin
most morphology. In exchange for a small proporti
2-ventricle repair, the institution achieved a low rate o
Y was a high-risk institution for death. The large prop
indicates that it favored neither a 2-ventricle nor Fon
Fontan pathways. For severe morphology, a large p
favorable morphology, a large proportion undergo 2
mortality rate is comparably low, and essentially, allThe method allows fair comparison of outcomes from dif-
The Journal of Thoracicferent institutions on the basis of different levels of risk
managed by each institution.
Several findings of the study deserve comment. Although
we and others have shown that tricuspid valve size is a
primary determinant of type of repair, our analysis reveals
that there are other variables to be considered. We demon-
strated that both tricuspid valve z score and RV size are
important determinants of achieving a 2-ventricle repair,
either early or late. Because tricuspid valve diameter and
individual institutions on the basis of morphologic
nd states (vertical axis) are plotted against tricuspid
All other predictors are set to their median value. A,
phology, a high proportion of 2-ventricle repairs is
peration is comparably low, mortality is high, and a
repair. B, Institution T favored the Fontan operation for
f neonates with favorable morphology receiving a
tality, particularly for severe morphology. C, Institution
n remaining alive at 5 years without definitive repair
athway. D, Institution E favored both 2-ventricle and
tion of neonates undergo the Fontan operation. For
ricle repair. Across the morphologic spectrum, the
ren have had a definitive repair at 5 years.for
of e
size.
mor
tan o
itive
on o
f mor
ortio
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-vent
childRV size were only moderately correlated, the inference is
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Dthat adequacy of both structures be considered when deter-
mining candidacy for 2-ventricle repair.10 In addition to
tricuspid valve size, tricuspid valve morphology is an im-
portant factor determining suitability for 2-ventricle re-
pair.17 Surrogated by RV enlargement and severe tricuspid
regurgitation in this study, associated Ebstein’s malforma-
tion imposes a high risk of death and not achieving 2-ven-
tricle repair. There are instances in which the size of the
right ventricle and tricuspid valve suggest potential for
2-ventricle repair, but tricuspid valve dysplasia precludes
reaching that outcome. Additionally, valves with an accept-
able z score might have stenotic dysplasia, with thickened
knobby leaflets and abnormal chordal attachments making
them irreparable. Because tricuspid valve replacement in
young children is undesirable, valve closure (often with a
patch) and proceeding to the Fontan operation might be the
best option.
We did not find aberrations of coronary circulation to be
specific risk factors for death, a finding supported by other
studies.12,13 When considered in the context of improving
overall survival, this finding lends further evidence that the
most unfavorable morphologic subsets of neonates with
PAIVS can be managed successfully. Because multiple
patient-related factors determine the appropriate protocol,
management decisions should be made after careful delin-
eation of presenting characteristics for each neonate.
In conclusion, we observed improving overall survival
across the span of the study. Furthermore, we estimate that
definitive repair could be achieved in 85% of neonates
within 3 to 5 years after admission. On the basis of factors
predicting repair pathway, we expect that 50% of neonates
will be suitable for 2-ventricle repair, and 35% will be more
appropriately managed on a Fontan pathway.
We thank all the CHSS members and their colleagues in
TABLE 3. Five-year prevalence of end-states for each risk
Institution n
High-prevalence
states 2-V repair
Institution E 20 2-V, Fontan 36% 28%
Institution M 9 2-V, Fontan 56% 29%
Institution T 19 Fontan 8% 8%
Institution L 14 2-V 47% 27%
Institution B 13 2-V 35% 23%
Institution Y 27 Death 17% 15%
Institution H 17 Death 25% 24%
Institution D 11 Death 28% 25%
Institution S 41 Death 18% 17%
Institution P 10 Death 19% 15%
Percentage value represents the predicted prevalence of each end-state
commensurate with TV z score, with all other predictors set at median valu
1.5-ventricle repair.pediatric cardiology for their contributions to the study and the
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Sally Cai) and institutional coordinators for collecting information
and following children. Also acknowledged are the contributions
of Drs R. M. Freedom, N. C. Nanda, and J. W. Kirklin in detailing
and recording morphologic data. Dr. Ashburn gratefully acknowl-
edges the financial support of the Bradshaw Fellowship in Surgical
Research from Wake Forest University School of Medicine.
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Discussion
Dr Roger B. B. Mee (Cleveland, Ohio). Dr Ashburn, I understand
that you are in the middle of a general surgical residency. Your
grasp of this complex subject and your presentation was outstand-
ing. I hope you choose to do congenital heart surgery.
In this study sophisticated statistical methods have been used to
tease out factors predisposing to the 6 end points: biventricular
repair, Fontan 1.5-ventricle repair, heart transplantation, death, or
still awaiting definitive repair. The performance of each of the 33
institutions has been analyzed, its cohort has been adjusted for
end-point risk factors, and an attempt has been made to define
pulmonary atresia–intact ventricular septum management strategy.
The overall mortality for the 408 patients from the period from
1987 through 1997, which was firmly within the modern era of
neonatal surgery, is disappointing—40% at 5 years—and over-
whelmingly clustered around neonatal palliation. There was a huge
mortality spread of 15% to 59% among institutions, and this
mortality was not related to volume, which I think is interesting.
A management strategy biased toward biventricular repair in-
creased the probability of achieving that end point but also in-
creased the possibility of death, and a bias toward a Fontan track
increased the probability of that end point and reduced the risk of
death.
The study’s conclusion was that with appropriate end-point
strategies, 85% of the cohort should have achieved repair end
points by 3 to 5 years, in particular 40% biventricular repair and
35% Fontan repair. Interestingly, these idealized end points are
identical to those reported in 1986 (reference 7 in the manuscript)
for a series of 48 patients in whom management strategy was based
simply on the presence or absence of a well-formed infundibulum.
From the database, identified risk factors for mortality before
definitive repair could be clustered into 2 groups: group A, very
small right ventricle and tricuspid valve, and right ventricle–
dependent coronary circulation, all of which are strongly related;
group B, very large right ventricle and tricuspid valve, low RV
pressure, severe tricuspid regurgitation, Ebstein’s anomaly, low
birth weight, and associated noncardiac abnormalities, including
hypoplastic lungs. With the 1997 cutoff, nearly all interventions
were surgical. In fact, I think if neonatal intervention was confined
to the catheter laboratory, most of those patients would not be
included because they would not be in our surgical databases.
I have 4 questions. If Ebstein’s anomaly requiring neonatal
surgical intervention was removed from the database, would this
eliminate or soften my group B risk factors for death?
The Journal of ThoracicSecond, can the database explain why some high-volume in-
stitutions had such high mortality?
Would it be possible to confirm from the current database that
the presence or absence of a well-formed infundibulum strongly
confers a large right ventricle and tricuspid valve, a very low
incidence of RV to coronary fistulas, and a virtual absence of right
ventricle–dependent coronary circulation and that an absent infun-
dibulum confers a very small right ventricle and tricuspid valve
and a high incidence of RV to coronary fistulas and includes all
cases of coronary stenosis and obstructions and right ventricle–
dependent coronary circulation and that this single factor would
just as accurately predict the idealized repair pathways that are the
conclusion of this study?
Finally, do you think it would now be appropriate and worth-
while to ask the contributing 33 institutions to supply data on all
neonates with neonatal interventions confined to the catheter lab-
oratory and to ascertain whether this approach represents an ad-
vance in terms of mortality and in achieving predicted end points?
Dr Ashburn. Thank you, Dr Mee. In regard to the first question
asking about the inclusion or exclusion of patients with associated
Ebstein’s malformation of the tricuspid valve, I do not think that
excluding those patients from this analysis would affect the risk
factors that we identified, nor do I believe that they would
“soften,” as you say, the group A or group B risk factors. The
reason I say that is because although Ebstein’s anomaly was not
specifically identified as a risk factor, there are at least 3 variables
in the risk factors that are surrogates for Ebstein’s anomaly.
There were 20 patients with Ebstein’s anomaly, and half had
RV enlargement and another half had severe tricuspid regurgita-
tion. I think that these risk factors are in the analysis that Ebstein’s
anomaly is actually surrogated for. Therefore these patients with
Ebstein’s anomaly, on the basis of their other characteristics,
would be expected to have a high risk of death, which is actually
seen.
In regard to the second question, why high-volume institutions
have a high risk of death, I cannot answer that specifically. What
I can say is that we adjusted institutional risk factors for patient
characteristics that were seen by that institution. Therefore I do not
believe that it is caused by differences in the patient population
that those institutions are seeing.
On the other hand, we do have data, and we showed a trend in
treating patients in a way that is concordant with their predicted
ultimate end point, and we were able to show that the institutions
that have improved outcomes are treating their patients in a more
concordant manner; that is, the management pathway matches
more often the predicted ultimate end point.
In regard to your third question, I know that your paper from
1986 showed that the status of the RV infundibulum is an excellent
predictor of the end state that a neonate can reach. Unfortunately,
our database does not have that specific piece of information in it.
The morphologic data were obtained by means of blinded inde-
pendent review done by 3 cardiologists looking at all catheteriza-
tions. I think it is logical to infer that a larger tricuspid valve size
and a larger right ventricle, as we have in our analysis and in our
risk factor set, probably does correlate to a better infundibulum,
but I do not have the data to show that.
In regard to your last question about retrospective enrollment of
neonates who underwent an initial interventional procedure, there
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patients, 7 had a biventricular repair, but I would also add that all
patients who ended up with a biventricular repair after an inter-
ventional procedure also had a shunt during the first admission.
I think that the current status of catheter intervention is differ-
ent than what we were seeing in the period of this study. Whether
enrolling patients retrospectively during that same time point now
would give us the data that we are looking for to compare catheter
intervention with surgical intervention, I am just not sure that it
would answer the specific questions we are looking for because
interventional procedures have changed so much, and I think their
outcomes have changed also.
Dr John E. Foker (Minneapolis, Minn). You have again con-
firmed that the results are poor for infants with PAIVS, the
mortality is high (40% at 5 years), and only 31% of survivors had
a 2-ventricle repair. The biggest source of difficulty is with those
who have very small right-sided hearts. We believe that the best
way to significantly improve these results will be to induce growth
of the hypoplastic ventricles. Induced growth will produce better
short-term and long-term results than will improved selection of
which patients should have 1-ventricle, rather than 2-ventricle,
repairs. Therefore the basic questions are as follows: Does an
adequate growth potential exist for these hypoplastic right-sided
hearts regardless of morphology, and can growth be relatively
rapidly induced?
Our hypothesis is that this is not a gene-level defect, and the
growth potential does exist. As we have shown, growth will be
induced by increased flow across the tricuspid valve. Therefore
after one relieves the RV obstruction, a mildly restrictive atrial
septal defect (gradient of 6 mm Hg) will encourage tricuspid flow
and yet allow sufficient right-to-left shunting for an adequate
cardiac output. In the interim pulmonary blood flow is preserved
by prostaglandin E1 infusion or, for very small right ventricles, a
1008 The Journal of Thoracic and Cardiovascular Surgery ● Aprshunt. The coronary-to-RV connections can be easily taken down
off bypass.
Our data indicate that all of these right ventricles will grow,
usually within days or weeks, even those with z values as low as
9. Catch-up growth clearly occurred. An infundibulum did not
seem to be necessary for adequate growth. Importantly, the tricus-
pid valves will also grow. The valves of 10 patients have been
analyzed. With an average beginning tricuspid z value of4, these
valves grew to an average value of 1. About 25% to 30% of the
smaller valves will have some degree of commissural fusion
apparent after growth. Significant stenoses will require balloon or
open valvotomy. Overall, our mortality is much lower (18% at 5
years), and very importantly, all located survivors had 2-ventricle
repairs.
My question is, have you analyzed your patients to establish the
growth potential of the right ventricle and tricuspid valves in those
infants who have had the outflow obstruction relieved? It has
frequently been stated that the ventricles and valves will not grow
adequately, and this belief turns therapy away from a 2-ventricle
repair. Our data clearly dispute this conclusion and approach.
Because the growth potential is such an important question, it
would seem that an analysis of your patients could provide this
vital answer.
Dr Ashburn. Thank you. We have not looked at repeated
measures of RV size and tricuspid valve size, and in response, I
would just state that I do not know of any literature that specifi-
cally shows that the right ventricle or tricuspid valve grow dispro-
portionately to somatic growth. In other words, certainly the right
ventricle and tricuspid valve might grow in relation to body
growth, but there is no so-called catch-up period, and I am just not
aware of literature showing that. But I think your point is well
taken that this would represent a good population to look at
repeated measures of RV size and tricuspid valve size to assess
right-sided heart growth capabilities.
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